Extracellular protein sensitizes ovarian cancer cells to chemotherapy

Dec 10, 2007

Scientists have uncovered critical new details about the mechanisms that modulate the response of ovarian cancer cells to chemotherapy. The research, published by Cell Press in the December issue of Cancer Cell, helps to explain why many patients develop resistance to the taxane class of drugs and may lead to improved treatment of ovarian cancer.

Cancer cells divide rapidly and undergo extensive microtubule-driven restructuring as they proliferate. Taxanes, such as paclitaxel (Taxol), interfere with the dynamic growth of microtubules by directly binding to them and making them more stable and, as a result, disrupt the normal process of cell division. Paclitaxel has been used extensively to treat lung, ovarian and breast cancers but drug resistance limits the clinical usefulness of this drug to only about half of breast or ovarian cancer patients.

Although it is clear that taxane resistance is associated with a loss of stable microtubules and that microtubule stability can be influenced by signals from the extracellular matrix (ECM), a role for ECM proteins in the modulation of paclitaxel sensitivity has not been established. To explore the connection between regulation of microtubules and taxane resistance, Dr. James D. Brenton from the Cancer Research UK Cambridge Research Institute in Cambridge, England and colleagues performed an extensive examination of ovarian cancer cell lines that were sensitive or resistant to paclitaxel.

The researchers found that the ECM protein, transforming growth factor beta induced (TGFBI), was significantly reduced in paclitaxel-resistant cells. Importantly, TGFBI mediated sensitization to paclitaxel and loss of TGFBI was sufficient to induce paclitaxel resistance. TGFBI induced microtubule stabilization that was dependent on integrin-mediated FAK and Rho signaling. Further, analysis of ovarian cancer samples taken after treatment with paclitaxel revealed that paclitaxel-induced cell death was associated with high levels of TGFBI expression.

These results identify TGFBI as an ECM protein that induces microtubule stability and modulates sensitivity to paclitaxel in ovarian cell lines and in patients receiving paclitaxel therapy. “Our findings have potentially significant clinical applications as TGFBI protein expression is lost in one third of primary ovarian and lung cancers and FAK is low or absent in one-third of ovarian cancer patients,” explains Dr. Brenton. “It is possible that TGFBI could be used as a biomarker for selecting patients likely to respond to taxane therapy. In addition, proteins that activate TGFBI or mimic its action may be an effective strategy for modulating the response to widely used drugs like paclitaxel or docetaxel.”

Source: Cell Press

Explore further: Oral cancer rates higher among rural men

add to favorites email to friend print save as pdf

Related Stories

Sharks off the menu and on the tourist trail in Palau

40 minutes ago

In many places swimmers might prefer to avoid sharks, but wetsuit-clad tourists in Palau clamour to dive among the predators thanks to a pioneering conservation initiative that has made them one of the country's ...

Single laser stops molecular tumbling motion instantly

1 hour ago

In the quantum world, making the simple atom behave is one thing, but making the more complex molecule behave is another story. Now Northwestern University scientists have figured out an elegant way to stop a molecule from ...

Top South America hackers rattle Peru's Cabinet

1 hour ago

The Peruvian hackers have broken into military, police, and other sensitive government networks in Argentina, Colombia, Chile, Venezuela and Peru, defacing websites and extracting sensitive data to strut ...

Great Barrier Reef dredge dumping plan could be shelved

1 hour ago

An India-backed mining consortium could shelve controversial plans to dump dredging waste in the Great Barrier Reef, with alternative sites on land being considered amid growing environmental concerns, Australia ...

Recommended for you

User comments : 0